knowledge -WSS

knowledge

author：hotspot 2025-09-27 16:50:20 - browse：551

ADAM FEUERSTEIN/STAT

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up here.

CHICAGO — It’s only Day 2, but the ASCO meeting is already in full force. That means hordes of oncologists filling the halls, reams of data streaming through the meeting, and incredibly long lines for even the worst food. And STAT reporters Angus Chen, Adam Feuerstein, and Matthew Herper are in the thick of it – on the heels of STAT’s own in-person event here, which was standing room only and came with its own share of thrills, chills, and not a little bit of audience laughter. More on that in a bit.

Here’s a rundown of some of the big news from the first 24 hours of the meeting which, due to some weird kind of relativistic time dilation, represents about a week for our intrepid reporters.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： How doctors’ personal politics affect patients

WSS

Heart disease and mental health: A look at cardiac psychology

Truvian presents data for its desktop blood

DeSantis can now import cheaper drugs. But will Biden get credit?

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Democrats decry new health bill for going easy on private equity

Fauci’s Covid grilling leads GOP to weigh foreign research rules

explore

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

explore

DIEP, the 'gold standard' of breast reconstruction, is under threat

Doulas covered by Medicaid under New York's new plan

As demand for Covid shots wanes, Moderna seeks its next success

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Medical records are filled with copy

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

In Memoriam: Notable people who died in 2023

Why patients can’t get everything they want on drug pricing

What does generative AI mean for health care? We asked experts

HHS names first

explore

What to watch for from Zogenix and Amicus clinical trials

What to watch for from Zogenix and Amicus clinical trials

Doulas covered by Medicaid under New York's new plan

Dems pitch expanding Medicare power to negotiate drug prices

Doulas covered by Medicaid under New York's new plan

A new crop of companies is reshaping the health data economy

entertainment

focus

hotspot

knowledge